T. LT； P GT； current invention； Oacute； N refers to synthetic products and amperes； Oacute； N Pharma Amp； EACUTE； enhanced oral coating compression process,Butenediol or its salts and amperes； Icatel； Effective and acceptable formaldehyde or its salts and amperes； Icatel； Effective and acceptable treatment of type 2 diabetes. The compound was obtained from Granulaci Amp； N H Amp； Oacute； N Pharma Amp； Eacute； UTICA； Granulaci Amp； Oacute； N AMP； UACUTE； MEDA.Using fine grinded formaldehyde and low prostate load,It consists of a polymer.In this case, Povidona and Magnesium Stearate acted as lubricants during compression and amperometry； Oacute； N. The fact that ground formaldehyde was used,It greatly improves people's understanding of it.At the same time, it can optimize the operating conditions. Composer and Ampere； Oacute； N Pharmacist and Ampere； eacute； improved utica,Knowing the combination of CI AMP, Oacute, N de Tenligiptina and Metformina,Comparing with the two existing principles,Vehicles in the form of sheetsThere is no difference in Liberaci Amp； Oacute； N in Vitro (Disclosi Amp； Oacute； N).On the other hand, what's better is thatCompressibility and cold compressibility of particles. These factors make this composition different from other N AMP components that contain the same assets and use more； UACUTE； purely from the prostate.So this is,1. The main purposes of the present invention are: Oacute； N. LT； / P GT；<；p>；LA PRESENTE INVENCIÓ；N SE REFIERE A UNA COMPOSICIÓ；N FARMACÉ；UTICA MEJORADA EN LA FORMA DE COMPRIMIDO ORAL RECUBIERTO, CON TENELIGLIPTINA O SUS SALES FARMACÉ；UTICAMENTE ACEPTABLES Y METFORMINA O SUS SALES FARMACÉ；UTICAMENTE ACEPTABLES PARA EL TRATAMIENTO DE DIABETES MELLITUS TIPO 2. DICHA COMPOSICIÓ；N FARMACÉ；UTICA ES OBTENIDA POR GRANULACIÓ；N HÚ；MEDA, UTILIZANDO METFORMINA MOLIDA A POLVO FINO Y BAJA CARGA DE EXCIPIENTES, CONSISTENTES EN UN AGLUTINANTE, EN ESTE CASO POVIDONA
